Top Wall Street Analysts Recommend Biotech Stocks With Over 100% Upside Potential
-
Stocks with highest upside potential according to top Wall Street analysts Intellia Therapeutics (206.98% upside), Rocket Pharmaceuticals (115.13%), Ultragenyx Pharmaceutical (114.53%)
-
Other stocks with large upside Denali Therapeutics (90.26%), Roivant Sciences (89.64%), Alibaba (81.72%)
-
Additional stocks to consider Baytex Energy (79.38%), Crescent Point Energy (72.36%), First Solar (69.44%)
-
Macroeconomic forecasts for 2024 mixed, with some predicting similar year to 2023 while others warn of plunge
-
Following macro forecasts challenging; top analyst stock recommendations could be better option